Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 2/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA3 | P07451 | 2/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | CA6 | P23280 | 2/20 | 0.31 |
| ▸ | CA5A | P35218 | 2/20 | 0.31 |
| ▸ | CA7 | P43166 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2055294 | 0.92 | LCK (0.55) | LCKNFKB1CHRM2CA12CA1 | |
| SCHEMBL7166448 | 0.89 | LCK (0.52) | LCKNFKB1CHRM2CA12CA1 | |
| SCHEMBL2055293 | 0.89 | LCK (0.52) | LCKNFKB1CHRM2 | |
| SCHEMBL176516 | 0.89 | LCK (0.52) | LCKNFKB1CHRM2CA12CA1 | |
| SCHEMBL43276 | 0.89 | LCK (0.52) | LCKNFKB1CHRM2CA12CA1 | |
| SCHEMBL33394 | 0.88 | LCK (0.48) | LCKNFKB1CHRM2LMNA | |
| SCHEMBL1062510 | 0.88 | LCK (0.48) | LCKNFKB1CHRM2LMNA | |
| SCHEMBL17123446 | 0.87 | LCK (0.52) | LCKNFKB1CHRM2CA12CA1 | |
| SCHEMBL15591980 | 0.87 | LCK (0.52) | LCKNFKB1CHRM2CA12CA1 | |
| SCHEMBL23549865 | 0.86 | LCK (0.50) | LCKNFKB1CHRM2CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116211887-A | Composition for treating acid-base imbalance | 特里赛达公司 | 2023-06-06 | — | — | CN | claimed |
| CN-111671766-A | Proton-binding polymers for oral administration | 特里赛达公司 | 2020-09-18 | — | — | CN | claimed |
| CN-111671767-A | Proton-binding polymers for oral administration | 特里赛达公司 | 2020-09-18 | — | — | CN | claimed |
| CN-105377270-B | Proton-binding polymers for oral administration | 特里赛达公司 | 2020-09-04 | — | — | CN | claimed |
| US-20190209607-A1 | COMPOSITIONS FOR TREATING ACID-BASE DISORDERS | TRICIDA, INC. | 2019-07-11 | — | — | US | claimed |
| EP-3287133-B1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | TRICIDA INC (US) | 2019-04-17 | — | — | EP | claimed |
| CN-109414453-A | composition for treating acid-base imbalance | 特里赛达公司 | 2019-03-01 | — | — | CN | claimed |
| EP-3812761-B1 | PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION | RENOSIS INC (US) | 2025-12-24 | — | — | EP | disclosed |
| US-20250222021-A1 | METHOD OF TREATING ACID-BASE DISORDERS | RENIBUS THERAPEUTICS, INC. | 2025-07-10 | — | — | US | disclosed |
| EP-4572882-A1 | PROCESS FOR PRODUCING MICROPARTICLES | BASF SE (DE) | 2025-06-25 | — | — | EP | disclosed |
| US-20250025494-A1 | COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | RENIBUS THERAPEUTICS, INC. | 2025-01-23 | — | — | US | disclosed |
| US-20250009785-A1 | HCL-BINDING COMPOSITIONS FOR AND METHODS OF TREATING ACID-BASE DISORDERS | RENIBUS THERAPEUTICS, INC. | 2025-01-09 | — | — | US | disclosed |
| US-11992501-B2 | Compositions for and methods of treating acid-base disorders | RENOSIS, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| EP-2044090-A2 | LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008008797-A2 | LUMINESCENT 1-HYDROXY-2-PYRIDINONE CHELATES OF LANTHANIDES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2008-01-17 | — | — | WO | disclosed |
| EP-0840727-B1 | 3-HYDROXY-2(1H)-PYRIDINONE CHELATING AGENTS | UNIV CALIFORNIA (US) | 2004-05-06 | — | — | EP | disclosed |
| US-5892029-A | HIGHLY EFFECTIVE UPON BOTH INJECTION AND ORAL ADMINISTRATION. | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-04-06 | — | — | US | disclosed |
| EP-0840727-A1 | 3-HYDROXY-2(1H)-PYRIDINONE CHELATING AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-05-13 | — | — | EP | disclosed |
| US-5624901-A | CARBAMOYL SUBSTITUTED COMPOUNDS FOR CHELATE COMPOUNDS FOR MAGNETIC RESONANCE IMAGING | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-04-29 | — | — | US | disclosed |
| WO-1997000245-A1 | 3-HYDROXY-2(1H)-PYRIDINONE CHELATING AGENTS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11992501-B2 | Compositions for and methods of treating acid-base disorders | SLC10A2, SLC10A1, SLC26A3 | LCK 4788/4885NFKB1 3854/4885CHRM2 2755/4885 |
| US-20250222021-A1 | METHOD OF TREATING ACID-BASE DISORDERS | SLC10A2, SLC10A1, SI | LCK 4187/4885NFKB1 3884/4885CHRM2 1836/4885 |
| US-20250009785-A1 | HCL-BINDING COMPOSITIONS FOR AND METHODS OF TREATING ACID-BASE DISORDERS | SLC10A2, SLC10A1, SLC7A1 | LCK 4702/4885NFKB1 3059/4885CHRM2 2397/4885 |
| US-20250025494-A1 | COMPOSITIONS FOR AND METHOD OF TREATING ACID-BASE DISORDERS | SLC10A2, SLC10A1, GLS | LCK 3361/4885NFKB1 4147/4885CHRM2 1741/4885 |
| US-20190209607-A1 | COMPOSITIONS FOR TREATING ACID-BASE DISORDERS | SLC10A2, SLC10A1, SLC26A3 | LCK 4777/4885NFKB1 3257/4885CHRM2 2467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.